
# CLARA-MeD Corpus


## Documents

The CLARA-MeD corpus version 1 gathers a collection of 24 298 pairs of professional and simplified texts (>96M tokens) for automatic medical text simplification in Spanish.

A parallel corpus with a subset of 3800 sentence pairs of professional and laymen variants (149 862 tokens) is released as a benchmark for medical text simplification. 

DISCLAIMER: this corpus was built for research and educational purposes. Because not all contents might be updated when using this resource, no medical decision should be taken from the data here provided. Please, check the current version of each source contents at the corresponding website (see below).


## Folders

1) Comparable corpus: the data of each source can be found in the corresponding folder. Each folder contains two other subfolders:

    - source: professional, specialized texts (".src" file extension)
    - target: simplified texts (".trg" file extension)

2) Aligned sentences: these can be found file "aligned.tsv" (in folder "aligned")

The folder structure is as follows:

    - aligned/
        - aligned.tsv
    - cima/
        - source/
        - target/
    - eudract/
        - source/
        - target/
    - nci/
        - source/
        - target/


## Distribution of drug leaflets and summaries of product characteristics from CIMA

The copyright of the contents belongs to Centro de Informaci—n de Medicamentos (CIMA, 'Medicine Online Information Center'), from the Agencia Espa–ola de Medicamentos y Productos Sanitarios (AEMPS). 

The latest access to the data was February 2022 from https://cima.aemps.es. Note that CIMA updates its contents regularly, and the data in the CLARA-MeD corpus might not be updated according to the version of the online contents.

The data can be reproduced (partially or totally), as long as the source is provided.

For more information, please, check: https://www.aemps.gob.es/avisoLegal/


## Distribution of clinical trials announcements from EudraCT

We attribute the source as "EU Clinical Trials Register" in the publication or distribution of these data, and clearly state that these data were accessed as of January 2022 from https://www.clinicaltrialsregister.eu.

The European Medicines Agency, according to current European Union and international legislation, is the owner of copyright and other intellectual property rights for documents and other content published on its website.

Information and documents made available on the Agency's webpages are public and may be reproduced and/or distributed, totally or in part, irrespective of the means and/or the formats used, for non-commercial and commercial purposes, provided that the Agency is always acknowledged as the source of the material. Such acknowledgement must be included in each copy of the material.

For further information, please, see: https://www.ema.europa.eu/en/about-us/legal-notice


## Distribution of cancer-related summaries from the National Cancer Institute

The data come from the Physician Data Queries (PDQ) at the National Cancer Institute (NCI): www.cancer.gov

Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without permission. Credit the National Cancer Institute as the source.

For further information, please, see: https://www.cancer.gov/policies/copyright-reuse


## Cochrane abstracts

These data cannot be distributed without permission from the Cochrane Collaboration (www.cochranelibrary.com).


## License

These data is aimed at research and educational purposes. 


## Contact

leonardo.campillos AT csic.es


## How to cite

If you use this corpus, please cite the reference as follows:

    Leonardo Campillos-Llanos, Ana Rosa Terroba, Sof’a Zakhir, Ana Valverde-Mateos & Adri‡n Capllonch-Carri—n
    Building a comparable corpus and a benchmark for Spanish medical text simplification
    Procesamiento del lenguaje natural, n¼ 69
    2022

